COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bill of Health
JANUARY 12, 2023
In 2005, they published their research and insights in a series of research papers and also filed a patent application disclosing this modification (which eventually issued as patent no. Moderna also licensed their mRNA technology from Cellscript LLC – University of Pennsylvania’s successor-in-interest to the 966 patent.
Let's personalize your content